Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic Periods.

Yun Wang Alexandre ChanRichard BeuttlerMarc L FlemingTodd SchneberkMichael NicholHaibing Lu

Published in: Healthcare (Basel, Switzerland) (2024)

Our findings differ in comparison to previous data regarding the raw monthly count of patients and prescriptions. The analysis encompassed uninsured patients, offering a comprehensive perspective on buprenorphine prescribing in California. Our study's insights contribute to understanding the impact of COVID-19 on buprenorphine access, emphasizing the need for policy adjustments.

Keyphrases

end stage renal disease
ejection fraction
coronavirus disease
sars cov
chronic kidney disease
newly diagnosed
primary care
public health
prognostic factors
patient reported outcomes
electronic health record
clinical evaluation